Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

Panos Zanos; Ruin Moaddel; Patrick J. Morris; Lace M. Riggs; Jaclyn N. Highland; Polymnia Georgiou; Edna F. R. Pereira; Edson X. Albuquerque; Craig J. Thomas; Carlos A. Zarate; Todd D. Gould

doi:10.1124/pr.117.015198

Keywords

KetaminePsychotomimeticPharmacologyDissociativeAnestheticAnalgesicAntidepressantNMDA receptorMedicinePhencyclidineDrugChemistryReceptorAnesthesiaInternal medicine

Affiliated Institutions

Related Publications

NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.

Martin R. Farlow

Research into Alzheimer's disease (AD) pathology has identified several underlying disease processes that are potential targets for drug discovery and development. One strategy ...

2004 PubMed 86 citations

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Undine E. Lang , Stefan Borgwardt

Depression is a multicausal disorder and has been associated with the risk to develop cancer, dementia, diabetes, epilepsy and stroke. As a metabolic disorder depression has bee...

2013 Cellular Physiology and Biochemistry 8484 citations

Induction of long‐term potentiation in the basolateral amygdala does not depend on NMDA receptor activation

Paul F. Chapman , Lisa L. Bellavance

Abstract Long‐term potentiation (LTP) can be induced in the lateral and basolateral amygdala by stimulating synaptic afferents in the external capsule (EC). We examined the sens...

1992 Synapse 117 citations

Control of cortical neuronal migration by glutamate and GABA

Heiko J. Luhmann , Atsuo Fukuda , Werner Kilb

Neuronal migration in the cortex is controlled by the paracrine action of the classical neurotransmitters glutamate and GABA. Glutamate controls radial migration of pyramidal ne...

2015 Frontiers in Cellular Neuroscience 146 citations

Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder

John Zajecka , Alan Schatzberg , Stephen M. Stahl +3 more

In this 8-week double-blind multicenter trial, we evaluated the efficacy and safety of 2 fixed doses of agomelatine in patients with moderate to severe major depressive disorder...

2010 Journal of Clinical Psychopharmacology 116 citations

Publication Info

Year: 2018
Type: review
Volume: 70
Issue: 3
Pages: 621-660
Citations: 1160
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1160

OpenAlex

Cite This

APA Style

                            
                                
                                    Panos Zanos, 
                                
                                    Ruin Moaddel, 
                                
                                    Patrick J. Morris
                                
                                et al.
                            
                            (2018). 
                            Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. 
                            Pharmacological Reviews
                            , 70
                            (3)
                            , 621-660.
                            https://doi.org/10.1124/pr.117.015198
                        

Identifiers

DOI: 10.1124/pr.117.015198